Halozyme Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence.
HALO Key Statistics
Stock Snapshot
With a market cap of 9.53B, Halozyme Therapeutics(HALO) trades at $81.01. The stock has a price-to-earnings ratio of 16.70.
On 2026-02-17, Halozyme Therapeutics(HALO) stock traded between a low of $79.17 and a high of $81.51. Shares are currently priced at $81.01, which is +2.3% above the low and -0.6% below the high.
Halozyme Therapeutics(HALO) shares are trading with a volume of 620.98K, against a daily average of 2.17M.
During the past year, Halozyme Therapeutics(HALO) stock moved between $47.50 at its lowest and $82.22 at its peak.
During the past year, Halozyme Therapeutics(HALO) stock moved between $47.50 at its lowest and $82.22 at its peak.
HALO News
Halozyme Therapeutics (NasdaqGS:HALO) has acquired three biotech startups as part of a broader push to expand its business. The company highlighted these trans...
In January 2026, Halozyme Therapeutics raised its 2026 total revenue guidance to a range of US$1.71 billion to US$1.81 billion, up from its prior outlook of US$...
Analyst ratings
60%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.